These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7805445)

  • 21. Changes in osteoblast, chondrocyte, and adipocyte lineages mediate the bone anabolic actions of PTH and small molecule GSK-3 inhibitor.
    Kulkarni NH; Wei T; Kumar A; Dow ER; Stewart TR; Shou J; N'cho M; Sterchi DL; Gitter BD; Higgs RE; Halladay DL; Engler TA; Martin TJ; Bryant HU; Ma YL; Onyia JE
    J Cell Biochem; 2007 Dec; 102(6):1504-18. PubMed ID: 17520664
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Studies on the mechanisms of the skeletal anabolic action of endogenous and exogenous parathyroid hormone.
    Goltzman D
    Arch Biochem Biophys; 2008 May; 473(2):218-24. PubMed ID: 18358824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of zinc in regulation of protein tyrosine phosphatase activity in osteoblastic MC3T3-E1 cells: zinc modulation of insulin-like growth factor-I's effect.
    Yamaguchi M; Fukagawa M
    Calcif Tissue Int; 2005 Jan; 76(1):32-8. PubMed ID: 15477998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro expression of osteoblastic markers in cells isolated from normal fetal and postnatal human bone and from bone of patients with osteogenesis imperfecta.
    Mörike M; Schulz M; Brenner RE; Bushart GB; Teller WM; Vetter U
    J Cell Physiol; 1993 Dec; 157(3):439-44. PubMed ID: 8253854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of glucose and its modulation by insulin and estradiol on BMSC differentiation into osteoblastic lineages.
    Gopalakrishnan V; Vignesh RC; Arunakaran J; Aruldhas MM; Srinivasan N
    Biochem Cell Biol; 2006 Feb; 84(1):93-101. PubMed ID: 16462893
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term culture in dexamethasone unmasks an abnormal phenotype in osteoblasts isolated from osteoporotic subjects.
    Rao LG; Murray TM; Wylie JN; McBroom RJ; Sutherland MK
    J Endocrinol Invest; 2005 Nov; 28(10):919-27. PubMed ID: 16419495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parathyroid hormone stimulates the proliferation of cells derived from human bone.
    MacDonald BR; Gallagher JA; Russell RG
    Endocrinology; 1986 Jun; 118(6):2445-9. PubMed ID: 3009159
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low-dose parathyroid hormone and estrogen reverse alkaline phosphatase activity suppressed by dexamethasone in mouse osteoblastic cells.
    Iu MF; Kaji H; Naito J; Sowa H; Sugimoto T; Chihara K
    J Bone Miner Metab; 2005; 23(6):450-5. PubMed ID: 16261451
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Growth stimulation of rat calvaria osteoblastic cells by acidic fibroblast growth factor.
    Rodan SB; Wesolowski G; Thomas K; Rodan GA
    Endocrinology; 1987 Dec; 121(6):1917-23. PubMed ID: 3678131
    [TBL] [Abstract][Full Text] [Related]  

  • 30. E64d, a membrane-permeable cysteine protease inhibitor, attenuates the effects of parathyroid hormone on osteoblasts in vitro.
    Murray EJ; Grisanti MS; Bentley GV; Murray SS
    Metabolism; 1997 Sep; 46(9):1090-4. PubMed ID: 9284902
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Direct modulation of osteoblastic activity with estrogen.
    Majeska RJ; Ryaby JT; Einhorn TA
    J Bone Joint Surg Am; 1994 May; 76(5):713-21. PubMed ID: 8175820
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parathyroid hormone potentiates the effect of insulin-like growth factor-I on bone formation.
    Spencer EM; Si EC; Liu CC; Howard GA
    Acta Endocrinol (Copenh); 1989 Sep; 121(3):435-42. PubMed ID: 2800920
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 17 beta-estradiol acts directly on the clonal osteoblastic cell line UMR106.
    Gray TK; Flynn TC; Gray KM; Nabell LM
    Proc Natl Acad Sci U S A; 1987 Sep; 84(17):6267-71. PubMed ID: 2819869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of cyclosporin A on rat osteoblasts (ROS 17/2.8 cells) in vitro.
    McCauley LK; Rosol TJ; Capen CC
    Calcif Tissue Int; 1992 Oct; 51(4):291-7. PubMed ID: 1330239
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The effects of titanium and hydroxyapatite on osteoblastic expression and proliferation in rat parietal bone cultures.
    Massas R; Pitaru S; Weinreb MM
    J Dent Res; 1993 Jun; 72(6):1005-8. PubMed ID: 8388412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Calcitonin (but not calcitonin gene-related peptide) increases mouse bone cell proliferation in a dose-dependent manner, and increases mouse bone formation, alone and in combination with fluoride.
    Farley JR; Hall SL; Tarbaux NM
    Calcif Tissue Int; 1989 Oct; 45(4):214-21. PubMed ID: 2509008
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison on the effects of three sex hormones on the fetal rat calvarial osteoblasts.
    Chen L; Zeng T; Xia W; Ke L
    J Tongji Med Univ; 2000; 20(1):59-62. PubMed ID: 12845760
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional properties of hormonally responsive cultured normal and malignant rat osteoblastic cells.
    Partridge NC; Alcorn D; Michelangeli VP; Kemp BE; Ryan GB; Martin TJ
    Endocrinology; 1981 Jan; 108(1):213-9. PubMed ID: 6936260
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stimulatory effects of estrogen and progesterone on proliferation and differentiation of normal human osteoblast-like cells in vitro.
    Scheven BA; Damen CA; Hamilton NJ; Verhaar HJ; Duursma SA
    Biochem Biophys Res Commun; 1992 Jul; 186(1):54-60. PubMed ID: 1632789
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Formulations for intermittent release of parathyroid hormone (1-34) and local enhancement of osteoblast activities.
    Jeon JH; Puleo DA
    Pharm Dev Technol; 2008; 13(6):505-12. PubMed ID: 18720235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.